Breaking News
Sort by:
Top Post
Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience
Rarity Bioscience announces a new strategic investment from Belgium-based Novalis Biotech. The investment is facilitated […]
OriCell Therapeutics Raises Over $120 Million in Series B Financing Led by Qiming Venture Partners and Quan Capital to Advance Cell Therapies for Cancer Immunology
OriCell Therapeutics (Shanghai) Co., Ltd. (“OriCell” or “the Company”) has announced the completion of Series B […]
Novasenta Completes $40 million Series A to Advance Novel Cancer Therapeutics
Novasenta Inc., a startup biotechnology company focused on the discovery and validation of novel targets […]
Diagnostic Robotics Closes $45m Series B Funding Round
Diagnostic Robotics, a leading provider of Artificial Intelligence & Care Management solutions for Healthcare plans […]
PayGround Raises $5.5M in Latest Funding Round
PayGround, a healthcare fintech payments platform, today announced the completion of a $5.5M funding round led by FCA […]
Theator Extends Series A Funding with Additional $24M for a Total of $39.5M
Theator, the creator of Surgical Intelligence, announced today that it has raised $24M in an extension of […]
Acuamark Diagnostics Secures $11.3 Million Series A Funding to Advance Innovative Assays for Improved, Cost-Effective Early-Cancer Detection
Acuamark Diagnostics (“AcuamarkDx”), an early cancer detection company, today announced the closing of an $11.3 million Series […]
Oncoustics Closes New Funding to Advance its AI Innovations in Ultrasound and Address Huge Unmet Clinical Needs in Liver Disease
Oncoustics (http://www.oncoustics.com), the leader in ultrasound-based tissue characterization solutions announces the initial close of a […]
Retia Medical Raises $15 Million to Accelerate Commercialization of the Argos Hemodynamic Monitor
Retia Medical, an innovator in advanced hemodynamic monitoring, today announced that it has secured $15 million in […]
Humanity Health Announces $6 Million Series A Funding Round
Humanity Health, the premier career acceleration and talent sourcing platform for underrepresented leaders in healthcare […]
Hansa Biopharma Announces $70 Million Non-dilutive Product Finance Transaction With NovaQuest to Support Continued Development of the Company's Antibody-cleaving Enzyme Technology Platform
Hansa Biopharma AB, (Hansa), (Nasdaq Stockholm: HNSA), a pioneer in enzyme technology for rare immunological […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more